Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1.

Translated title of the contribution: Significance of the evaluation of C-peptide in children with type 1 diabetes mellitus

E. Gandullia, E. Bonioli, R. Monteverde, M. F. La Fauci, M. Lattere, C. Augeri, R. De Grandi, M. Chiossi, M. G. Alpigiani

Research output: Contribution to journalArticle

Abstract

In type I diabetes mellitus (DM) the presence of C peptide (Cp), whose determination is unaffected by exogenous insulin, is considered expression of a residual beta-cell activity, which allows a better metabolic control. In 35 children affected by type I DM the fasting Cp was measured: in 18 cases (1st group) a value greater than or equal to 1 ng/ml was observed, while in the remaining 17 (2nd group) the Cp value was less than 1 ng/ml. A statistical comparison between the two groups demonstrated that in the first one a better metabolic control was achieved with a daily lower insulin dosage. Moreover in the 1st group the onset of the disease was more recent, while there was no difference between the two groups with regard to the age at diagnosis. The Cp evaluation and follow-up is useful in the assessment of the individual case; furthermore, on the basis of these studies, an immunosuppressive treatment may be considered during the early phase of the disease, when a residual beta-cell activity is demonstrated.

Original languageItalian
Pages (from-to)687-689
Number of pages3
JournalPediatria Medica e Chirurgica
Volume8
Issue number5
Publication statusPublished - Sep 1986

Fingerprint

C-Peptide
Type 1 Diabetes Mellitus
Insulin
Immunosuppressive Agents
Fasting
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Gandullia, E., Bonioli, E., Monteverde, R., La Fauci, M. F., Lattere, M., Augeri, C., ... Alpigiani, M. G. (1986). Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1. Pediatria Medica e Chirurgica, 8(5), 687-689.

Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1. / Gandullia, E.; Bonioli, E.; Monteverde, R.; La Fauci, M. F.; Lattere, M.; Augeri, C.; De Grandi, R.; Chiossi, M.; Alpigiani, M. G.

In: Pediatria Medica e Chirurgica, Vol. 8, No. 5, 09.1986, p. 687-689.

Research output: Contribution to journalArticle

Gandullia, E, Bonioli, E, Monteverde, R, La Fauci, MF, Lattere, M, Augeri, C, De Grandi, R, Chiossi, M & Alpigiani, MG 1986, 'Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1.', Pediatria Medica e Chirurgica, vol. 8, no. 5, pp. 687-689.
Gandullia E, Bonioli E, Monteverde R, La Fauci MF, Lattere M, Augeri C et al. Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1. Pediatria Medica e Chirurgica. 1986 Sep;8(5):687-689.
Gandullia, E. ; Bonioli, E. ; Monteverde, R. ; La Fauci, M. F. ; Lattere, M. ; Augeri, C. ; De Grandi, R. ; Chiossi, M. ; Alpigiani, M. G. / Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1. In: Pediatria Medica e Chirurgica. 1986 ; Vol. 8, No. 5. pp. 687-689.
@article{4a2259c4937f46c89cdef9f025f8bd80,
title = "Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1.",
abstract = "In type I diabetes mellitus (DM) the presence of C peptide (Cp), whose determination is unaffected by exogenous insulin, is considered expression of a residual beta-cell activity, which allows a better metabolic control. In 35 children affected by type I DM the fasting Cp was measured: in 18 cases (1st group) a value greater than or equal to 1 ng/ml was observed, while in the remaining 17 (2nd group) the Cp value was less than 1 ng/ml. A statistical comparison between the two groups demonstrated that in the first one a better metabolic control was achieved with a daily lower insulin dosage. Moreover in the 1st group the onset of the disease was more recent, while there was no difference between the two groups with regard to the age at diagnosis. The Cp evaluation and follow-up is useful in the assessment of the individual case; furthermore, on the basis of these studies, an immunosuppressive treatment may be considered during the early phase of the disease, when a residual beta-cell activity is demonstrated.",
author = "E. Gandullia and E. Bonioli and R. Monteverde and {La Fauci}, {M. F.} and M. Lattere and C. Augeri and {De Grandi}, R. and M. Chiossi and Alpigiani, {M. G.}",
year = "1986",
month = "9",
language = "Italian",
volume = "8",
pages = "687--689",
journal = "Pediatria Medica e Chirurgica",
issn = "0391-5387",
publisher = "Vicenza Pediatria Medica E Chirurgica",
number = "5",

}

TY - JOUR

T1 - Interesse della valutazione del peptide C nel bambino affetto da diabete mellito tipo 1.

AU - Gandullia, E.

AU - Bonioli, E.

AU - Monteverde, R.

AU - La Fauci, M. F.

AU - Lattere, M.

AU - Augeri, C.

AU - De Grandi, R.

AU - Chiossi, M.

AU - Alpigiani, M. G.

PY - 1986/9

Y1 - 1986/9

N2 - In type I diabetes mellitus (DM) the presence of C peptide (Cp), whose determination is unaffected by exogenous insulin, is considered expression of a residual beta-cell activity, which allows a better metabolic control. In 35 children affected by type I DM the fasting Cp was measured: in 18 cases (1st group) a value greater than or equal to 1 ng/ml was observed, while in the remaining 17 (2nd group) the Cp value was less than 1 ng/ml. A statistical comparison between the two groups demonstrated that in the first one a better metabolic control was achieved with a daily lower insulin dosage. Moreover in the 1st group the onset of the disease was more recent, while there was no difference between the two groups with regard to the age at diagnosis. The Cp evaluation and follow-up is useful in the assessment of the individual case; furthermore, on the basis of these studies, an immunosuppressive treatment may be considered during the early phase of the disease, when a residual beta-cell activity is demonstrated.

AB - In type I diabetes mellitus (DM) the presence of C peptide (Cp), whose determination is unaffected by exogenous insulin, is considered expression of a residual beta-cell activity, which allows a better metabolic control. In 35 children affected by type I DM the fasting Cp was measured: in 18 cases (1st group) a value greater than or equal to 1 ng/ml was observed, while in the remaining 17 (2nd group) the Cp value was less than 1 ng/ml. A statistical comparison between the two groups demonstrated that in the first one a better metabolic control was achieved with a daily lower insulin dosage. Moreover in the 1st group the onset of the disease was more recent, while there was no difference between the two groups with regard to the age at diagnosis. The Cp evaluation and follow-up is useful in the assessment of the individual case; furthermore, on the basis of these studies, an immunosuppressive treatment may be considered during the early phase of the disease, when a residual beta-cell activity is demonstrated.

UR - http://www.scopus.com/inward/record.url?scp=0022771185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022771185&partnerID=8YFLogxK

M3 - Articolo

C2 - 3299288

AN - SCOPUS:0022771185

VL - 8

SP - 687

EP - 689

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 5

ER -